Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)

BACKGROUND: Anogenital warts are the second most common sexually transmitted infection diagnosed in sexual health services in England. About 90% of genital warts are caused by human papillomavirus (HPV) types 6 or 11, and half of episodes diagnosed are recurrences. The best and most cost-effective t...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Macey L., Meadows, Jade, Doré, Caroline J., Copas, Andrew J., Haddow, Lewis J., Lacey, Charles, Jit, Mark, Soldan, Kate, Bennett, Kate, Tetlow, Michelle, Nathan, Mayura, Gilson, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220496/
https://www.ncbi.nlm.nih.gov/pubmed/30400777
http://dx.doi.org/10.1186/s12874-018-0581-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220496/
https://www.ncbi.nlm.nih.gov/pubmed/30400777
http://dx.doi.org/10.1186/s12874-018-0581-z

Ejemplares similares